Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	361
Overall Study	STARTED	5 mg Tadalafil	363
Overall Study	STARTED	0.2 mg Tamsulosin	185
Overall Study	Received at Least One Dose of Study Drug	Placebo	361
Overall Study	Received at Least One Dose of Study Drug	5 mg Tadalafil	362
Overall Study	Received at Least One Dose of Study Drug	0.2 mg Tamsulosin	185
Overall Study	COMPLETED	Placebo	337
Overall Study	COMPLETED	5 mg Tadalafil	346
Overall Study	COMPLETED	0.2 mg Tamsulosin	174
Overall Study	NOT COMPLETED	Placebo	24
Overall Study	NOT COMPLETED	5 mg Tadalafil	17
Overall Study	NOT COMPLETED	0.2 mg Tamsulosin	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01937871/flow